Stephens Consulting’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.58K | Buy |
+3
| New | +$1.58K | ﹤0.01% | 551 |
|
|
2025
Q1 | – | Sell |
-21
| Closed | -$15K | – | 1547 |
|
|
2024
Q4 | $15K | Hold |
21
| – | – | ﹤0.01% | 306 |
|
|
2024
Q3 | $22.1K | Sell |
21
-4
| -16% | -$4.21K | 0.01% | 250 |
|
|
2024
Q2 | $26.3K | Buy |
+25
| New | +$26.3K | 0.01% | 238 |
|
|
2023
Q4 | – | Sell |
-100
| Closed | -$82.3K | – | 502 |
|
|
2023
Q3 | $82.3K | Buy |
+100
| New | +$82.3K | 0.03% | 125 |
|
|
2022
Q4 | – | Sell |
-29
| Closed | -$20K | – | 543 |
|
|
2022
Q3 | $20K | Hold |
29
| – | – | 0.02% | 251 |
|
|
2022
Q2 | $17.1K | Hold |
29
| – | – | 0.01% | 258 |
|
|
2022
Q1 | $20.3K | Hold |
29
| – | – | 0.02% | 265 |
|
|
2021
Q4 | $18.3K | Buy |
+29
| New | +$18.3K | 0.02% | 301 |
|